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The investigation of gd T cells has identified a rapid lymphoid stress-surveillance response to microbial and
nonmicrobial tissue perturbation. In addition to providing local protection, this response provides an imme-
diate source of cytokines, chemokines, and other functions that can substantially affect downstream, adap-
tive immunity. Recent studies have identified strikingmechanisms bywhich gd cellsmeet the requirements of
stress surveillance. For example, high response frequencies can reflect a unique nature of antigen engage-
ment by the T cell receptor (TCR), developmental focusing of the repertoire by selection events, or the use
of nonclonotypic receptors to initiate responses. Likewise, rapid functional deployment can be facilitated
by the preprogramming of gd cells during development. Additionally, gd cells can directly influence adaptive
immunity by functioning as antigen-presenting cells. With lymphoid stress surveillance likely to underpin
numerous aspects of inflammation, tumor immunology, infectious disease, and autoimmunity, this perspec-
tive considers its properties and its emerging potential for clinical manipulation.Introduction
Work from many groups has collectively composed a compelling
description of immune surveillance that links the rapid activation
of myeloid cells (dendritic cells [DC], monocytes [MO], and
macrophages [mf]) to the delayed mobilization of antigen-
specific lymphocytes (Banchereau and Steinman, 1998). The
key initiators of events are innate pattern recognition molecules,
such as Toll-like receptors (TLRs). These provoke myeloid cells
to deploy local effector responses, recruit other immunocytes,
and migrate to local lymphoid tissue, where they present anti-
gens to rare, cognate T lymphocytes (Medzhitov and Janeway,
2000). Following the time required for their clonal expansion,
their cellular differentiation, and their migration to the affected
tissue, such pathogen-specific lymphocytes elaborate pleio-
tropic effector and immunoregulatory functions that vary accord-
ing to context. Additionally, some commit to a memory pool,
which responds more rapidly and effectively to secondary chal-
lenge. The ligands for TLRs and other pattern recognition recep-
tors comprise a spectrum of microbial and viral molecules
(Medzhitov and Janeway, 2000). Hence, the system elegantly
describes the surveillance of infection, and its actions can
entirely eradicate a pathogen (Figure 1A).
The immune surveillance of nonmicrobial stress is less well
elucidated. Although DCs and monocytes will respond to ‘‘stress
signals’’ such as ureate and adenosine triphosphate (ATP)
released from dying cells (Rock and Kono, 2008), many ‘‘stress
antigens’’ may not be recognized by myeloid cells (Janeway,
et al., 1988). Among these are the MHC Class-I-related gene
products, MICA (human) and RAE-1 (mouse), that are upregu-
lated on epithelial cells by myriad physicochemical perturbations
and that are commonly expressed by tumor cells and by inflam-
matory sites, such as the pancreas of diabetes-prone NOD mice
(Groh et al., 1996, 1999; Ogasawara et al., 2004). They can also184 Immunity 31, August 21, 2009 ª2009 Elsevier Inc.be upregulated, directly or indirectly, during certain infections.
These and other stress antigens are recognized by NK cells,
CD8+ memory T cells, and large numbers of ‘‘unconventional’’
T lymphocytes, of which gd cells are the prototype (Groh et al.,
1998; Hayday, 2000; Girardi et al., 2001). Following stress-
antigen engagement by any of several receptors (that may
include the TCR), unconventional T cells can rapidly initiate a
‘‘lymphoid stress-surveillance response’’ that is not delayed by
obligatory clonal expansion or de novo differentiation (Fig-
ure 1B) (Strid et al., 2008). Moreover, this form of immune
response may also be deployed when unconventional T cells en-
counter common, life-threatening microbes such as mycobacte-
ria and malaria (Constant et al., 1994; D’Ombrain et al., 2007).
Although unlikely to sterilize a host of a specific pathogen,
lymphoid stress surveillance can quickly limit the dissemination
of infected or malignant cells, sustain tissue integrity, and regu-
late the nature and scale of downstream adaptive responses,
thus emphasizing the biological integration of unconventional
and conventional lymphocytes (Pennington et al., 2005). As a
consequence, lymphoid stress surveillance is increasingly impli-
cated in scenarios of tumor immunology (Girardi et al., 2001;
Strid et al., 2008), inflammation (Romani et al., 2008; Martin
et al., 2009), allergy (Lopez-Vazquez et al., 2002; Hu¨e et al.,
2004), autoimmunity (Hayday and Geng, 1997; Roark et al.,
2007; Jensen et al., 2008), and infectious disease (Constant
et al., 1994; D’Ombrain et al., 2007; King et al., 1999; Wang
et al., 2006; Shibata et al., 2007; Hamada et al., 2008) that are
not fully explained by conventional innate and adaptive immu-
nity. In this perspective, we shall consider how stress-surveil-
lance lymphocytes can be so rapidly yet safely activated, how
they can so promptly provide immune functions, and how they
contribute to host pathophysiology. Although stress surveillance
is mediated by several types of unconventional lymphocytes
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and clinical potential.
Activating gd Cells
The primary activating receptor for conventional T cells is the
T cell receptor, which combines with costimulatory receptors,
such as CD28, to drive clonal expansion. gd cells irrefutably
expand upon stimulation in vivo (Caldwell et al., 1995). However,
stress surveillance is not compatible with delays that would be
incurred by cell expansion, and human gd cells adoptively trans-
ferred to immunodeficient mice immediately mount immunopro-
tective responses to bacterial infection prior to cell expansion
(Wang et al., 2001). This requires a high frequency of responding
gd cells, activated by autologous stress antigens, commonly
encountered pathogens, or both. The prospect that gd TCR
engagement might initiate such responses is evident from the
nature of putative gd antigens, which include self-MHC-related
proteins, self and microbial pyrophosphates, a form of the F1-
ATPase, and a Herpes virus glycoprotein (Figure 2) (Hayday,
2000; Scotet et al., 2005). Moreover, ‘‘crossover’’ reactivity to
microbial and nonmicrobial dysregulation (Figure 2) is illustrated
by human Vd1(+) cells displaying dual TCR-dependent responses
toward carcinomas and toward cytomegalovirus (CMV)-infected
cells (Halary et al., 2005; D. Vermijlen, personal communication.).
Unique Modes of TCR Engagement
A detailed understanding of the gd TCR may reveal its suitability
for stress surveillance. In this regard, Surface Plasmon Reso-
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Figure 1. Tissue Stress Surveillance
(Top) Conventional, microbe-initiated activation of
the local, myeloid cell-mediated innate response
and its communication of information to the adap-
tive T and B cell compartments.
(Bottom) The lymphoid stress-surveillance
response is initiated by many forms of nonmicro-
bial as well as microbial stress that upregulate
surface expression of ligands for TCRgd or for
NKG2D, to which the T cells are competent to
respond because of other receptor-ligand
‘‘context interactions’’. The question mark denotes
that the full scope of this stress-surveillance
response has yet to be determined.
nance (SPR) has demonstrated direct
binding of two independently derived gd
TCRs to the murine MHC-I-related pro-
teins, T10 and T22, that is expressed by
highly activated cells (Adams et al., 2005,
2008). Cell staining withmultimericT22 es-
tablished this reactivity to be shared by1
in 200 peripheral murine gd cells (Shin
et al., 2005), which is probably within an
order of magnitude of the representation
of virus-specific cytolytic T cells in a
conventional ab T cell memory compart-
ment. Thus, the primary response to T10
and T22 is oligoclonal and potentially
rapid, capturing the essence of stress
surveillance.
Although MHC-I related, T10 and T22 do not present peptides
or lipids and are recognized as an intact protein via contacts with
an extended complementarity-determining region (CDR)3 loop
of TCRDd (Adams et al., 2005, 2008). T10- and T22-reactive
loops share a 6 amino acid ‘‘core’’ that includes five germline-
encoded residues (Shin et al., 2005) and that can confer T10
and T22 reactivity on a heterologous ab TCR (Adams et al.,
2008). This defines a unique means of TCR-antigen engagement.
A similar focusing of ligand-binding on CDR3 may underpin
the observation by Vermijlen and colleagues that human
Vd1Vg1.8+ cells enriched in neonates exposed in utero to CMV
display a single, public CDR3g and a single CDR3d (D.Vermijlen,
personal communication). Because there is substantial diversity
among TCRgd CDR3 lengths, the confinement of ligand binding
to this region might accommodate highly heterogeneous anti-
gens (Rock et al., 1994; Hayday, 2000). Thus, another murine
gd clone recognizes an epitope of the MHC-II molecule, I-Ek,
outside the peptide-binding region (Hampl et al., 1999).
The prospect of heterogeneous antigen recognition by TCRgd
is indirectly supported by recent experiments showing that the
pMHC-restriction of TCRab is substantially imposed by CD8
and CD4 (Van Laethem et al., 2007). By sequestering the protein
kinase, p55-LCK, these coreceptors direct the signaling
machinery toward ab TCRs that, together with CD8 and CD4,
engage MHC. In mice lacking CD4 and CD8, LCK becomes
freely available, permitting ab TCRs to select on non-MHC
ligands (Van Laethem et al., 2007). Since most gd cells lack
CD4 and CD8, their reactivities would not be constrained,Immunity 31, August 21, 2009 ª2009 Elsevier Inc. 185
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gens (Figure 2). Indeed, as more TCRgd ligands are elucidated,
it will be interesting to determine whether they comprise mole-
cules whose major function is to regulate immunity (as we
conventionally view MHC) or molecules with intrinsic function(s)
related to cellular dysregulation, e.g., heat shock proteins.
Antigen Presentation to gd T Cells
Because the studies of T10 and T22 reactivity have been so
informative, it is important to consider how representative they
may be. T10 and T22, like MHC-I, require b2-microglobulin
(b2M), and yet, b2M-deficient mice do not share the immune
dysregulation of gd cell-deficient mice (see below) (Hayday,
2000). These and other data suggest that most gdTCR-ligands
are not b2M-dependent. Moreover, the negligible contribution
of CDR1 or CDR2 to T10 or T22 binding is not easily reconciled
with the seeming importance of these regions implied by tissue-
associated pairings of single Vg and Vd segments (e.g., human
peripheral blood gd cells are largely Vg9Vd2+, murine dendritic
epidermal T cells (DETCs) are largely Vg5Vd1+, and murine
reproductive gd cells are largely Vg6Vd1+) (Hayday, 2000). It is
possible that these types of gd TCR follow the TCRab paradigm,
wherein CDR1 and CDR2 engage an antigen-presenting
element, while diverse CDR3 regions engage different cargoes
(Rock et al., 1994).
In this regard, two human Vd1+ lines react to CD1c, which can
present self and microbial lipid-based antigens (Figure 2) (Spada
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For T cells to be suitable for stress surveillance,
they recognize a spectrum of molecules signifying
dysregulation. These molecules may be self-
encoded TCR and NKG2D ligands (T10 and T22,
P-antigens, MICA, etc.), or non-self-encoded,
e.g., common products of multiple pathogens
(HMBPP), unique products of very common path-
ogens (e.g., putative CMV or Herpes ligands), or
TLR ligands. The cells can then deploy several
types of function appropriate to different types of
stress, directed against non-self or self targets.
The responses are negatively regulated via inhibi-
tory receptors for MHC-I, UPA, and probably other
ligands.
et al., 2000). However, the clones showed
no obvious lipid specificity, and although
their CDR3 regions were not similar, their
recognition might be of intact CD1c,
akin to T10 or T22 reactivity. Because
CD1c is upregulated during inflamma-
tion-induced monocyte differentiation
into DC, it seems ideally placed to
promote stress surveillance by gd cells.
Thus, the system merits further analysis.
By contrast, one heavily investigated
area is the TCR-dependent reactivity of
human Vg9Vd2+ cells toward low-molec-
ular-mass phospho(P)-antigens (Figure 2)
(Pfeffer et al., 1990; Constant et al., 1994;
Tanaka et al., 1994; Hayday, 2000). Con-
sistent with the stress-surveillance model, P-antigens may be
autologous, such as isoprenylpyrophosphate (IPP), which accu-
mulates in many virus-infected or transformed cells (Hayday,
2000; Gober et al., 2003), or microbial, such as hydroxymethyl
but-2-enyl pyrophosphate (HMBPP), a metabolic intermediate
specific to many prokaryotes and apicomplexan parasites
such as malaria (Figure 2) (Eberl et al., 2003). Of clinical interest,
aminobisphosphonates, which are widely prescribed for osteo-
porosis and malignancy, indirectly activate Vg9Vd2+ cells by in-
hibiting farnesyl pyrophosphate synthase, which provokes IPP
accumulation (Kunzmann et al., 1999).
There is a compelling case for a P-antigen-presenting element
(Miyagawa et al., 2001). P-antigens are too small to crosslink the
TCR: repeated attempts to demonstrate TCR binding have
failed; the limitation of reactivity to Vg9Vd2+TCRs suggests
that CDR1 and CDR2 contribute to ligand engagement, whereas
P-antigen-reactive Vg9Vd2+TCRs display diverse CDR3 regions
that might accommodate different pyrophosphate cargoes;
trypsin treatment of target cells impairs P-antigen recognition
(Wei et al., 2008); and despite containing P-antigens, mouse
cells cannot activate P-antigen-reactive Vg9Vd2+ cells, consis-
tent with the lack of a presenting element and the absence of
P-antigen reactivity in rodents (Wei et al., 2008).
The putative presenting element might soon be identified by
Morita and colleagues, who recently reported binding of photo-
affinity HMBPP analogs to tumor cells that promote P-antigen
responses (Sarikonda et al., 2008). Those experiments excluded186 Immunity 31, August 21, 2009 ª2009 Elsevier Inc.
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senting element is an ectopic form of mitochondrial F1-ATPase,
expressed in cell surface complexes with extracellular apolio-
protein-A(ApoA)1 (Figure 2) (Scotet et al., 2005). ‘‘Ecto-F1-AT-
Pase’’ has catalytic and noncatalytic binding sites for polyphos-
phates and would seem well suited to bind APPPi, a nucleotidic
(and possibly biologically active) form of IPP, expressed by
Vg9Vd2-activating cells (Mo¨nkko¨nen et al., 2007). Bead-bound
ATPase stimulates Vg9Vd2+ cells, whereas cells expressing
low amounts of Ecto-F1-ATPase show poor aminobisphospho-
nate-induced Vg9Vd2+ activation, consistent with its contribu-
tion to P-antigen recognition (Scotet et al., 2005; P. Vantourout,
personal communication). SPR demonstrated direct binding of
soluble Vg9Vd2 to soluble ApoA1 and to F1-ATPase subunits
(Scotet et al., 2005), and although no biochemical data describe
P-antigen binding to such a complex, this may reflect technical
limitations. Were Ecto-F1-ATPase to activate Vg9Vd2+ cells by
presentation of nucleotidyl P-antigens, it might reflect some
parallels with the activation of monocyte inflammasomes by
extracellular ATP.
The Need for Focus
The postulated recognition of diverse, ‘‘stress-associated’’
P-antigens or other cargoes complexed to one or more antigen-
presenting elements would accommodate the high potential for
diversity in TCRgd CDR3 and the gd repertoire dominance by
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Figure 3. Repertoire Focusing
For T cells to be suitable for stress surveillance,
their response times must be rapid, and therefore,
their precursor frequency must be high. In this
figure, the homogenization of the repertoire to
a set of (red) gd cells may be achieved in any of
several ways: (1) the high frequency generation
of an antigen combining site by gene rearrange-
ment in progenitor thymocytes; (2) positive selec-
tion events mediated via the TCR (A) or other
receptors selectively expressed by some gd
thymocytes (B); (3) negative selection of thymo-
cytes through TCR engagement (C); and (4) pe-
ripheral activation and expansion of large numbers
of cells via nonclonotypic receptors such as
NKG2D. A check mark indicates mechanisms for
which experimental evidence exits for natural gd
compartments.
particular Vd and Vg pairings (Hayday,
2000). However, the time taken to sample
diverse cargoes would not be consistent
with rapid stress surveillance. Potential
resolutions of this conundrum are them-
selves diverse. For example, the gd cell
compartment may be truly heteroge-
neous, with some cells displaying conven-
tional, adaptive responsiveness, rather
than contributing to rapid stress sur-
veillance. This might explain occasional
reports of primate pathogen-specific
memory gd cells (Shen et al., 2002) and
emerging evidence for antigen-specific
memory within the large bovine and
ovine gd compartments (Hogg et al., 2009). However, because
resting primate gd cells seldom express lymph node (LN) homing
receptors, it is not clear where and how they would meet the
challenge of sampling diverse antigen and undergoing cognate
T cell expansion (Brandes et al., 2003). Conversely, constitutive
homing of many gd cells to tissues seems more consistent with
oligoclonal activation by commonly encountered antigens (Jane-
way et al., 1988). This would be the case if the set of stress-asso-
ciated cargoes is limited in diversity and the precursor frequency
of cognate peripheral gd cells is selectively focused during devel-
opment.
Any of several mechanisms may focus the gd repertoire
(Figure 3). Because T10 and T22 reactivity focuses on a short
CDR3d core, the high precursor frequency (1/200 gd cells)
may simply reflect the frequency (0.85%) with which VDJ-recom-
bination generates the relevant sequence (Shin et al., 2005)
(Figure 3). This does not exclude additional mechanisms, such
as a popular agonist-selection model in which progenitors of gd
cells or other unconventional T cells are positively selected by
engagement of a TCR-agonist that subsequently activates the
corresponding mature cells in the periphery (Hayday and Pen-
nington, 2007). However, this was not observed when T22 multi-
mers were used to track antigen-reactive gd+ thymocytes in
strains with differential T10 and T22 expression (Jensen et al.,
2008). Ligand engagement influenced the phenotype of reactive
TCRgd+ thymocytes (see below) but did not enrich for them.Immunity 31, August 21, 2009 ª2009 Elsevier Inc. 187
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cells from all other known T cells. Reconciling this to an obligate
need for gdTCR signaling during differentiation, Chien and
colleagues provided evidence for ligand-independent TCRgd
signaling by spontaneous dimerization (Jensen et al., 2008).
Murine TCRgd is certainly distinct from TCRab, by failure to asso-
ciate with CD3d (Siegers et al., 2007), and by possession of resi-
dues analogous to those that mediate preTadimerization (Jensen
et al., 2008; Yamasaki et al., 2006). Dimerization offered a long-
sought explanation for ligand-independent, preTCR-mediated
election of ab T cell progenitors (Hayday and Pennington,
2007). However, a conserved isoform of preTa (pTab) can support
substantial preTCR function (Gibbons et al., 2001), despite lack-
ing three of four residues required for dimerization. Thus, the
contributions of dimerization to preTCR function are unresolved,
and by analogy, dimerization may make important but incom-
plete contributions to gd cell differentiation. Indeed, it is possible
that T10- and T22-reactive thymocytes engage additional
ligands, akin to abTCR reactivity toward distinct selecting and
agonist pMHC complexes. For example, the ‘‘AND’’ abTCR
recognizes pigeon cytochrome C restricted by I-Ek, is ordinarily
positively selected on I-Ab, and also selects in mice lacking all
MHC (Van Laethem et al., 2007). Mason previously considered
that antigen receptors must be highly crossreactive, and ‘‘tonic
signaling’’ by low-affinity engagement of myriad self-determi-
nants has been implicated in B cell and ab T cell survival (Mason,
1998; Stadanlick et al., 2008). If similar interactions provide
ligand-mediated repertoire focusing, then gd cell development
might not be so different from that of other T cells.
The studies of T10- and T22-reactive cells also showed that
cognate ligand did not negatively select reactive cells, although
there was some evidence of this for cells with relatively high-
affinity TCRs (e.g., high tetramer staining). Although consistent
with agonist selection, it is hard to conceive that negative selec-
tion is not widely required, given the likelihood that gd gene-
segment rearrangement can generate pathogenic, high-affinity,
self-reactive TCRs (Figure 3). During B cell development, BCR
engagement promotes apoptosis, which is countered by signals
from TNF-like ligands, such as BLyS (Stadanlick et al., 2008).
Because high-affinity BCR signals are too strong to counter,
strongly self-reactive cells are negatively selected, whereas
moderate affinity cells survive. Possibly a similar situation
applies to gd cells, combining positive and negative selection
in a single step and implying a gd analog of BLyS.
Focusing with and without the TCR
It was recently shown that the selective maturation and intrathy-
mic expansion of murine thymocytes expressing the DETC-
associated Vg5Vd1 TCR depends on the expression by thymic
epithelium of Skint1, the prototype of an immunoglobulin super-
family of at least six Skint genes (Lewis et al., 2006; Boyden et al.,
2008). Because Skint1 does not affect any other gd cells, it
contributes to repertoire focusing (Figure 3). It also fulfils many
criteria of an ‘‘agonist selector’’: its expression is limited to the
thymus and epidermis, the sites of DETC development and func-
tion, respectively (Boyden et al., 2008); its effects on thymocytes
can be phenocopied by a TCR agonist (Lewis et al., 2006); and
substantial overexpression of transgenic Skint1 does not nega-
tively select DETC (S. Barbee and A.C.H., unpublished data).188 Immunity 31, August 21, 2009 ª2009 Elsevier Inc.Interestingly, the Vg5Vd1 DETC-TCR lacks putative dimerization
residues (see above), and hence, ligand engagement may be
particularly important for cells expressing it. However, there
are currently no data that SKINT1 binds the TCR. This notwith-
standing, Skint1 defines a critical axis of communication
between thymic stroma and gd cell progenitors. Moreover, the
identification of a unique immunoglobulin superfamily through
the study of gd cells emphasizes the cells’ distinct biology and
suggests that studies of other unconventional T cells may iden-
tify other unique receptor-ligand axes that underpin stress
surveillance.
High-response frequencies to ‘‘stress’’ could also be achieved
if gd cells respond via non-clonally-restricted receptors, inde-
pendent of the TCR. For conventional CD8+ T cells, TCR engage-
ment ultimately results in selectively expanded, rapidly respon-
sive memory cells. Having avoided negative selection, having
been successfully primed, and having survived peripheral regu-
lation, such cells should be both efficacious and safe to reacti-
vate, independent of the TCR. Consistent with this, cytokines
and TLR ligands can rapidly evoke IFNg from polyclonal CD8+
memory cells with profound effects on adaptive immunity (Leg-
gat et al., 2008).
For peripheral gd cells, a constitutive ‘‘activated yet resting’’
state is largely acquired developmentally (Pennington et al.,
2003; Silva-Santos et al., 2005), akin to the ‘‘natural memory’’
of NKT cells and marginal zone B cells (Martin and Kearney,
2000). The cells’ efficacy may have been established in heredi-
tary rather than somatic time. For example, gene rearrangement
bias and positive selection mechanisms will have evolved that
favor TCRs reactive to microbial antigens (e.g., HMBPP) or autol-
ogous stress antigens (e.g., IPP or T10 and T22) that were
commonly encountered over generations. If the potential patho-
genicity of such cells is limited by repertoire focusing, then it may
be safe and efficacious to activate them independently of the
TCR, using receptors such as NKG2D (Figure 3).
NKG2D is commonly viewed as a primary activator of NK
cells and a costimulator of gd cells and CD8+ memory T cells
(Groh et al., 1998, 2001; Bauer et al., 1999). NKG2D ligands
comprise several MHC-1-related molecules encoded in humans
by MICA, MICB, and several RAET1 (a.k.a. ULBP) genes and in
mice by at least three H60 genes, at least 5 Rae-1 genes, and
the Mult gene (Raulet, 2003). NKG2D-ligand expression is
increased (in some cases from zero) by myriad nonmicrobial
stresses and some infections, particularly of epithelial cells
(Groh et al., 1996; Girardi et al., 2001; Gasser et al., 2005). Consis-
tent with lymphoid stress surveillance, cultured human gd T cells
kill MICA+ cells, seemingly independently of the TCR (Rincon-
Orozco et al., 2005). And yet, transfected insect cells expressing
NKG2D ligandscould not activate NK cells (Bryceson et al., 2005).
The question, therefore, is whether NKG2D engagement is suffi-
cient to initiate lymphoid stress surveillance in vivo (Figure 1).
This was examined in transgenic mice in which Raet1b was
selectively induced de novo in otherwise normal epidermis by
a molecular switch, rather than by pleiotropic stress agents
(Strid et al., 2008). This provoked a rapid reorganization of the
epidermal immune compartment: dendritic epidermal gd cells
and Langerhans cells (LC) became rounded and activated.
Because LC lack NKG2D, their activation was presumably
induced by responding gd cells, consistent with which gd cell
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were soon followed by an epidermal infiltration of NKT cells,
evocative of that reported in psoriasis (Cameron et al., 2002).
Thus, this example of lymphoid stress surveillance in vivo intro-
duces a novel information flux: challenge to epithelial cell to
unconventional T cell to DC to other lymphocytes. This contrasts
with the conventional information flow: challenge to DC to T cells
(Figure 1). Furthermore, our unpublished studies demonstrate
that primary antigen responses to epicutaneously applied oval-
bumin are substantially enhanced by ongoing NKG2D ligand up-
regulation, further highlighting the integration of unconventional
and conventional lymphocytes (Pennington et al., 2003, 2005).
The study poses several major questions. For example, does
this formof stress surveillance apply to other tissues and species?
Which gd cell functions does it evoke? Which receptor-ligand
interactions provide the context for RAE-1 to act as a primary
activator in vivo (Figure 1)? And how might it interact with con-
ventional TLR-mediated responses to coincidental infection?
Theexperimental system mightalsoaddress the unresolved issue
of NKG2D-ligand multiplicity. Perhaps different ligands exist to
outflank viral immunoevasion of single ligands (Eagle and Trow-
sdale, 2007; Arapovic et al., 2009). Alternatively, by engaging
NKG2D with different affinities (O’Callaghan et al., 2001), different
ligands may stimulate NKG2D+ cells to deploy different effectors
appropriate to different forms of afferent stress. The contribution
of the TCR during NKG2D-initiated stress surveillance is also
unclear. Possibly it maintains a tonic signal, permitting NKG2D
to serve as a rate-determining step for cell activation (Figure 1B).
This issue is somewhat complicated by SPR (and other) data that
MICA may directly engage human Vg1Vd1 TCRs, albeit weakly
compared to NKG2D (Zhao et al., 2006). There is no evidence
that RAE-1 does likewise in the mouse.
Lymphoid stress surveillance will also be activated by other
ligand-receptor axes. For example, two studies in this issue of
Immunity describe TCR-independent activation of polyclonal
gd cells via pattern recognition receptors and cytokines, respec-
tively (Sutton et al., 2009; Martin et al., 2009), analogous to the
activation of conventional memory cells. Like memory CD8+
T cells, human gd cells also express functional forms of TLR3
and TLR7 (Figure 2) (Wesch et al., 2006; Gibbons et al., 2009).
Costimulation, Preactivation, Localization,
and Thresholds
NKG2D-mediated initiation of stress surveillance does not
exclude its potential to costimulate gd cells. For conventional
T cells, costimulation provides critical evidence that antigen is
being encountered in the context of bona fide dysregulation.
Without it, antigen challenge provokes T cell tolerance. From
this perspective, NKG2D-ligands would communicate an appro-
priate ‘‘stress context’’ for gd TCR-ligand engagement in vivo.
Indeed, H60c, a murine NKG2D ligand expressed by keratino-
cytes, can costimulate Vg5Vd1+ DETC in vitro (Whang et al.,
2009). Likewise, signals via CD28, which is expressed by some
lymphoid gd cells, presumably provide an ‘‘infection context’’ for
TCRgd engagement. DETC and intestinal IEL also express the
junctional adhesion-like molecule-1 (JAML1) that costimulates
cells following engagement of the Coxsackie-Adenovirus
receptor (CAR), which presumably communicates some form of
epithelial dysregulation (Witherden et al., 2009). This notwith-standing, it is not clear that default tolerance describes the
response of peripheral gd cells to TCR engagement. Rather,
akin to conventional memory cells (whose safety and efficacy
has been tested [see above]), gd cell responses may not need to
be contextualized by costimulation. Indeed, many gd cells
express receptors (e.g., 4-1BB, CD30, and PD1) associated with
effector-memory T cells (Fahrer et al., 2001; Shires et al., 2001).
Such molecules may contribute to various aspects ofgd cell regu-
lation, for example, by limiting their expansion (see below), by
enhancing effective target cell adhesion, or by directing the tissue
homing that permitsgdcells access to the early stages of infection
and malignancy. Indeed, how unconventional T cells are directed
to and retained within specific tissues is only poorly understood.
Independent of conventional costimulation, the metabolic
capacity of T cells to respond to agonists will require cytokines
or Notch ligands, collectively termed ‘‘signal 3.’’ In this respect,
intestinal intraepithelial gd cells are rich in RNAs encoding recep-
tors for TSLP, TNFa, LIF, and IL-21 (Shires et al., 2001), with
IL-21 emerging as a major regulator of gd cells, as it is for NK
cells (Nurieva et al., 2007). Likewise, TCR engagement upregu-
lates the IL-2Rb chain (CD122) on gd cells, increasing respon-
siveness to IL-15, for which epithelia and DC are rich sources
(Edelbaum et al., 1995). IL-15 in turn upregulates NKG2D, further
increasing the cells’ potential for stress surveillance, in a posi-
tively reinforcing loop that can promote enteropathy-associated
lymphomagenesis (Hu¨e et al., 2004; Meresse et al., 2004).
Probably all cell activation is regulated by inhibitory receptors.
Human peripheral blood Vg9+Vd2+ cells express phosphatase-
recruiting receptors of the KIR and CD94-NKG2A families, for
which MHC-I is the best-characterized ligand. Thus, MHC-I
can set activation thresholds for stress surveillance, akin to
‘‘missing self’’ regulation of NK cells. Indeed, intestinal IEL acti-
vation in celiac disease appears contingent on downregulation
of inhibitory NK receptors. Although the murine equivalents of
KIRs, encoded by the Ly49 genes, also bind MHC-I, it was unex-
pectedly reported that the Ly49E receptor, expressed by a
subset of DETC and their thymic progenitors, mediates inhibi-
tion in response to urokinase plasminogen activator (UPA) (Van
Den Broeck et al., 2008). Whereas UPA is usually associated
with vascular biology, clotting, fibrinolysis and matrix regulation,
its expression is also elevated in wound healing. Thus, although
there is currently no evidence for direct UPA-Ly49E binding, this
intriguing work may have identified a means to downregulate
lymphoid stress-surveillance during recovery.
Other means of regulation may include ‘‘negative costimula-
tors’’ such as PD-1, which underpins exhaustion of conventional
effector CD8+ T cells in chronic virus infections and which may
likewise limit gd cell expansion following infection. Possibly,
PD1-PD1L blockade could reverse Vg9Vd2+ cell anergy ob-
served in many HIV-infected individuals (Poccia et al., 1997).
Cells may also become ‘‘tuned’’ to routinely encountered con-
centrations of activating ligands (Grossman and Paul, 1992).
Such ‘‘experience’’ might be heritably integrated by microRNAs
that regulate phosphatases (Li et al., 2007) and thereby set
activation thresholds. Germane to this, chronic versus acute
upregulation of transgenic RAE-1 or MICA profoundly sup-
presses gd cells and NK cells (Oppenheim et al., 2005; Wiemann
et al., 2005). Although this was primarily attributed to NKG2D
downregulation, responses to other modes of activation wereImmunity 31, August 21, 2009 ª2009 Elsevier Inc. 189
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results were recently reported for NK cells in transgenic mice
constitutively expressing the activating ligand m157 (Tripathy
et al., 2008; Sun and Lanier, 2008). Reciprocally, non-NKG2D-
mediated NK cell responses were exaggerated in NKG2D-defi-
cient mice (Zafirova et al., 2009). Such tuning may limit the
potential for chronic tissue inflammation but may also provide
opportunities for immunoevasion. Indeed, the fundamental
importance of the NKG2D stress-surveillance axis is evident in
the adoption, by tumors and by viruses as diverse as Herpes,
adenoviruses, and pox, of myriad counter strategies, including
retention of NKG2D-ligands within infected cells, shedding of
NKG2D-ligands that suppress responsive cells, a MICB-specific
microRNA, and secretion of a high affinity virus-encoded
competitor for NKG2D (Dunn et al., 2003; Kaiser et al., 2007;
Campbell et al., 2007; Stern-Ginossar et al., 2007; McSharry
et al., 2008).
Functional Pleiotropy of Stress-Surveillance Responses
The pleiotropy of conventional CD4 T cells seems limitless, with
different conditions favoring IL-2, IL-4, IFNg, IL-9, IL-10, TGFb,
IL-17, IL-22, etc., in various combinations. Such functional diver-
sification resides in myriad ‘‘induction motifs’’ elicited in different
DC by different microbial recognition pathways and cytokines
and communicated to T cells during priming. This delayed differ-
entiation is incompatible with lymphoid stress surveillance. Thus,
it has been commonplace to view gd cells as homogeneous,
cytolytic cells producing IFNg, TNFa, and chemokines such as
lymphotactin and RANTES. This perspective is supported by
functional studies in vitro and gene profiles that reveal high
expression of cytolytic mediators, such as granzyme (GZM) B
and TRAIL, together with GZM C and other molecules previously
attributed to NK cells (Fahrer et al., 2001; Shires et al., 2001; Ver-
mijlen et al., 2007). Clearly, such effectors could offer protection
in the early stages of infection and carcinogenesis (Girardi et al.,
2001). However, the picture is woefully incomplete: gd cells are
highly pleiotropic, with the rapid release of sundry cytokines
and chemokines having profound implications for both local
and systemic responses (Born et al., 1999; Martin et al., 2009)
(Figure 2).
The earliest reported phenotypes of infected gd T cell-defi-
cient (Tcrd/) mice were immunopathologies attributable to
exaggerated ab T cell responses (Born et al., 1999; Hayday
and Tigelaar, 2003). This implies that lymphoid stress surveil-
lance senses internal as well as external threats to tissue integ-
rity. Although the underlying mechanisms are unresolved, gd
cells express many candidate immunoregulatory gene products,
including Tgfb, Lag-3, and Ltb4 (Lymphoid thymosin b4) (Shires
et al., 2001). Interestingly, some effects are exerted locally.
Thus, DETCs exert cutaneous immunoregulation by targeting
the effector adaptive response in the skin rather than the priming
phase in the LNs (Hayday and Tigelaar, 2003). This evokes the
localized suppression of transplant-graft rejection by CD4+ regu-
latory T cells. gd cells may also confer immunoregulation indi-
rectly, for example, by enhancing epithelial resistance to infil-
trating ab T cells.
Related to this, gd cells were the first T cells implicated in
promoting epithelial cell growth (Figure 2) (Jameson and Havran,
2007). Such contribution to tissue integrity would seem appro-190 Immunity 31, August 21, 2009 ª2009 Elsevier Inc.priate to stress surveillance, although this property is now recog-
nized in many T cells and immunocytes that may stimulate
epithelial cells via insulin-like growth factor-1 (IGF1), IL-22,
IL-6, amphiregulin, and most likely other mediators. Ironically,
such activities may ultimately damage tissues by promoting
tumor growth (Roberts et al., 2007; Grivennikov et al., 2009).
Closure of full-thickness wounds over a 7 day period is delayed
in Tcrd/mice (Jameson and Havran, 2007), and it was recently
shown that skin gd cells from patients with chronic wound-heal-
ing deficits are anergic and unable to express epithelial growth
factors, in contrast to those from unafflicted or acutely wounded
skin (Toulon et al., 2009). Hence, whereas murine DETCs have no
overt human equivalent, lessons learned from these and other
unconventional T cells can powerfully extrapolate to human
health and disease.
Antigen-Presenting gd Cells
Among the most provocative recent developments concerning
gd cell function are Moser and colleagues’ reports that
antigen-activated human Vg9Vd2+ T cells (but not ab T cells)
take up and process antigen, and either present it on MHC-II
(expressed by all activated primate T cells), or cross-present it
on MHC Class-I (Brandes et al., 2005, 2009) (Figure 2). This
would directly integrate lymphoid stress surveillance with
systemic adaptive immunity. In fact, this revelation is an impor-
tant, well-crafted progression of a decade-old report that bovine
gd cells present antigen to CD4+ ab T cells (Collins et al., 1998).
gd cells are good candidates for antigen-presenting cells
(APCs). Complementing Moser’s work, Gustafsson and col-
leagues found that activated human gd cells efficaciously phago-
cytose E.coli or latex beads and will present peptides derived
from influenza virus M1 protein that had been complexed to
the beads (K. Gustafsson, personal communication). Moreover,
activated human gd cells express the immunoproteasome,
rather than the constitutive proteasome that is expressed by
most cells, including immature DC. To prime naive T cells, acti-
vated gd T cells need to enter LNs and provide costimulation.
Interestingly, Vg9Vd2+ cells activated via the TCR and certain
cytokines upregulate LN-homing receptors; express CD80,
CD86, or CD40; and can expand peptide-specific T cell lines
starting from pools of naive CD4+ or CD8+ T cells (Brandes
et al., 2003, 2005; K. Gustafsson, personal communication).
Thus, one may hypothesize that TCR-mediated, NKG2D-medi-
ated, or TLR-mediated activation rapidly provokes gd cells in
inflammatory sites or tissues to deploy local effector functions,
to activate and recruit other immunocytes, and to migrate to
LNs wherein they prime conventional T cells. This evokes
emerging evidence that NK cells access LNs and regulate Th1
priming (Martı´n-Fontecha et al., 2004) and that many other cells,
e.g., basophils, can present antigen (Sokol et al., 2008). Thus, the
unique contributions of gd cells to antigen presentation may be
to respond to stimuli not recognized by other APCs. Additionally,
if the fine details of antigen processing were different between
APCs, then gd cells could extend the repertoire of peptides avail-
able to conventional T cells. The implication of gd cells in antigen
presentation reminds us that APCs, such as DCs, B cells, gd
cells, and basophils, can act as both effector cells and APCs,
in which regard the conventional primed T cell (that does not
present antigen) may be exceptional.
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gd cells argues that gd-APC function is not critical, this does
not diminish its potential importance in humans. Indeed,
crosspresentation is key to stress surveillance because this
is a primary means by which dying tumor cells (for example,
following chemotherapy) are taken up, processed, and pre-
sented to CTLs. It is likewise relevant to microbial infection.
Although crosspresentation in mice has been largely assigned
to CD8aa+ DC, there is scope for gd cells to contribute to this
in humans. Further parallels of Vg9Vd2+ cells with myelomono-
cytic APC include the expression of Fc-receptors. Indeed,
P-antigens have been used in the clinic to enhance the capacity
of gd cells to mediate antibody-dependent cell-mediated cyto-
toxicity (ADCC), thereby optimising the efficacy of therapeutic
antibodies (Gertner-Dardenne et al., 2009).
gd-17 Cells
The potential of gd cells to provide stress surveillance was
illustrated a decade ago by evidence that gd cells limit lung
pathology induced either by ozone or by infection by the gram-
positive bacterium, Nocardia asteroides (King et al., 1999).
Because Nocardia spread is limited by neutrophils, and given
the recent avalanche of interest in neutrophil activation by IL-
17-producing T cells, it was natural to assess whether gd cells
make IL-17 during the early phase of a response (Figure 2).
Indeed, rapid IL-17 production in response to bacteria as diverse
as mycobacteria, E.coli, and Listeria is attributable to gd cells
rather than TCRab+ Th17 cells (Umemura et al., 2007; Shibata
et al., 2007; Hamada et al., 2008). Moreover, Matsuzaki and
colleagues described pulmonary IL-17 expression within one
day of BCG infection, attributed most of it to gd cells, and
showed it depended on IL-23 (as do Th17 cells) (Umemura
et al., 2007). These results are extended in this issue of Immunity
by evidence that gd cells produce IL-17 in direct response to
IL-23 and to microbial agonists of the TLR1, TLR2, and dectin
receptors that gd cells may express (Martin et al., 2009). Concur-
rent with the implication of IL-17 in autoimmunity, gd-17 cells
were found in comparable numbers to TCRab+ Th17 cells in
the draining lymph nodes of collagen-induced arthritis (CIA)
models (Roark et al., 2007). Likewise, the longstanding implica-
tion of gd cells in experimental allergic encephalomyelitis (EAE)
models has now been assigned to gd-17 cells (Hayday and
Geng, 1997; Jensen et al., 2008; Sutton et al., 2009). In neither
case is the stimulus for gd cell involvement resolved, but the oli-
goclonality of gd cells in the CIA model suggests a TCR-driven
response (Roark et al., 2007). Likewise T10 and T22, along
with other MHC-I molecules, can be strongly expressed in the
brain (Huh et al., 2000), creating the potential for gdTCR-medi-
ated neuropathology. Rapid IL-17 production may be very
important, because neutrophils, in addition to being immunopro-
tective, can skew ensuing adaptive responses. Moreover, gd-17-
derived IL-17 promotes IL-17 production by TCRab+ Th17 cells
(Sutton et al., 2009).
Speed Is Important
How do gd cells achieve the rapid production of cytokines
required by the stress-surveillance response? A clue to this
emerged in the finding that gd-17 cells are IL-6 independent
(Lochner et al., 2008). Because Th17 cells lose IL-6 dependenceafter initial activation, the result suggested that peripheral gd-17
cells might be preactivated. In this regard, Silva-Santos’s and
Pennington’s groups recently assigned IFNg-production cells
to a CD27+ subset that contains most of the gd cells in the
spleen, LNs, lung, and other tissues, and IL-17 production to
the CD27() subset (Ribot et al., 2009). This functional segrega-
tion was emphasized by the failure of CD27+ cells to secrete
IL-17 under any conditions that evoke Th17 cells, whereas
CD27() cells readily produced IL-17 independently of cytokines
required for Th17 cells (Ribot et al., 2009). There was negligible
interconversion of these disparate phenotypes, even during gd
cell activation and expansion following malaria infection. Analo-
gous studies segregated gd cells into IFNg-producers and IL-17-
producers, by high levels of CD122 and the scavenger receptor,
SCART2, respectively (Jensen et al., 2008; Shibata et al., 2008;
Kisielow, et al., 2008). However, CD27 does not simply mark
gd differentiation but, rather, is a determinant of gd cells pro-
ducing high amounts of IFNg (Ribot et al., 2009).
Strikingly, such functional determination begins in the thymus
(Shibata et al., 2008; Jensen et al., 2008; Ribot et al., 2009).
Thus, recently matured TCRgd+ fetal thymocytes show preprog-
rammed polarization toward IFNg or IL-17 production that is per-
turbed in Cd27/ mice. Interestingly, Chien and colleagues
found that IFNg or IL-17 production also segregated among
T10- and T22-reactive thymocytes, with those engaging cognate
ligand being CD122hi IFNg-producers and those (with identical
TCRs) that did not engage T10 or T22 emerging as CD122lo,
IL-17 producers (Jensen et al., 2008). By use of CD122 and other
parameters, the authors suggested that most developing gd
thymocytes are ‘‘nonselected,’’ IL-17 producers, which seems
at odds with the relative abundance of IFNg-producing gd cells
in the periphery. This notwithstanding, these independent studies
provide pivotal mechanistic insight into the developmental pre-
programming ofgdcell differentiation. Moreover, the involvement
of TCR-ligand engagement in preprogramming suggests that
Born and O’Brien’s long-standing correlation of gd cell function
with TCR usage (O’Brien et al., 2007) might simply reflect the like-
lihood that a particular TCR will encounter its cognate-agonist in
the thymus or will more readily form a signaling dimer.
The data do not exclude some peripheral plasticity of gd cell
function, and murine and human gd cells can express IL-4, and
provide B cell help under specific conditions (Hayday, 2000).
Indeed, IL-21 activated human Vg9Vd2+ cells share with follicular
T-helper cells the production of the B cell-activating chemokine,
CCL13 (Vermijlen et al., 2007). Nonetheless, developmental
preprogramming seems an important property of lymphoid
stress-surveillance, and its existence in humans was recently
suggested when gd cells of neonates born up to 10 weeks
prematurely, were found to produce IFNg (and not IL-17) at birth,
as efficaciously as cells exposed to the environment for one
month (Gibbons et al., 2009). Such preprogrammed capabilities
may be particularly important because neither murine nor human
neonatal ab T cells can produce IFNg.
We do not know how gd cell development phenocopies the
peripheral differentiation of conventional T cells. Although
common factors seem to be involved, e.g., T-bet and eomeso-
dermin for IFNg-producing cells and RoRgt for IL-17 producing
cells (Ribot et al., 2009), there are some interesting differences.
For example, conventional Th17 cell differentiation is intertwinedImmunity 31, August 21, 2009 ª2009 Elsevier Inc. 191
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outcome partly resolved by RUNX-factor interactions with RoRgt
and FOXP3 (Collins et al., 2009). Because gd cells rarely activate
FOXP3 (Pennington et al., 2006), the development of gd-17 cells
may be more facile. Whether such differences reflect distinct
properties of gd-lineage progenitors or the effects of gdTCR
signaling is largely unresolved (Hayday and Pennington, 2007).
Developing gd cells diverge from ab progenitors during the
CD4()CD8() ‘‘double-negative’’ (DN) phase of early thymocyte
differentiation, as illustrated by transgenic mice in which thymo-
cytes differentiating as gd cells become fluorescently labeled.
These mice revealed a DN stage 3 checkpoint at which a newly
generated gd TCR promotes massive expansion and maturation
of cells prior to their exiting the thymus with a signatory ‘‘preac-
tivated’’ phenotype (Prinz et al., 2006). To date, such signatory
differentiation has not been ascribed to any gd lineage-specific
transcription factor and is probably an integrated product of
cell-intrinsic programmes and interactions with stromal cells
and other thymocytes (Silva-Santos et al., 2005; Hayday and
Pennington, 2007). Interestingly, many gene signatures of the
‘‘activated yet resting’’ state are expressed by early DN thymo-
cytes, being gradually extinguished during conventional ab
T cell differentiation rather than acquired de novo during gd
differentiation (Pennington et al., 2003; Silva-Santos et al.,
2005). Once conventional T cells pass the ‘‘safety and efficacy
tests’’ of selection, priming, and regulation and enter the memory
pool (see above), they may reinduce such genes, reassuming the
‘‘activated yet resting’’ state.
The Impact of gd Cells In Vivo
The value of stress surveillance can be inferred from the pheno-
types of mice lacking unconventional T cells and stress-surveil-
lance molecules, respectively. Mice lacking gd cells commonly
display exaggerated ab T cell responses with associated immu-
nopathologies (Born et al., 1999; Hayday and Tigelaar, 2003).
Beyond this, the importance of gd cells was consistently under-
valued because of the failure to demonstrate antigen-specific,
immunoprotective roles in commonly used laboratory infection
systems. This situation is changing because of an increased
focus on the complex pathophysiology of natural infections.
Thus, gd cells are now cited as essential, innate providers of
cytokines and other effector molecules during the early stages
of infection or tissue dysregulation (Martin et al., 2009). Although
this is completely consistent with lymphoid stress surveillance,
results are often case specific, cautioning against sweeping
generalizations. For example, gd-deficient mice produce less
IFNg in response to mycobacterial infection (Umemura et al.,
2007), but more in response to Chlamydia (Yang et al., 1998);
likewise, gd-deficiency limits neutrophil responses to Nocardia
(King et al., 1999), but not to Listeria (Fu et al., 1994).
gd Cells and Infectious Diseases
gd cells are the first IFNg-producing T cells in ontogeny in mice
and in humans and make essential contributions to host protec-
tion in early life (Ramsburg et al., 2003; Gibbons et al., 2009).
Thus, their study should redress our poor understanding of im-
mune responses in the most vulnerable. Adults display consider-
able variation in peripheral blood gd cells (0.2%–20% of
T cells), analogous to that in NKT cells, although steady-state192 Immunity 31, August 21, 2009 ª2009 Elsevier Inc.levels of both cell types are conspicuously stable longitudinally.
This notwithstanding, substantial gd cell expansions, sometimes
exceeding 50% of the CD3+ pool, are transiently provoked by
bacterial and protozoal infections where HMBPP is produced
(see above) (Caldwell et al., 1995; Eberl et al., 2003). The signif-
icance of this is illustrated by the recent report that rapid IFNg
responses to malaria infection of children in Papua New
Guinea owe mostly to gd cells, rather than NK or CD8+ T cells
(D’Ombrain et al., 2007) (Figure 2). Human gd cells have likewise
long been associated with mycobacterial lesions (Tanaka et al.,
1994; Constant, et al., 1994; Hayday, 2000), and show imme-
diate effector responses to bacterial infection after adoptive
transfer to SCID mice (Wang et al., 2001). Tcrd/ mice show
some exacerbation of BCG growth and reduced elaboration of
the key protective cytokine, IFNg. Somewhat unexpectedly,
this may be attributable to a defect in the early gd-17 response
to BCG infection (Umemura et al., 2007). Likewise, depletion of
resident Vd1+ cells impaired early IL-17 production and protec-
tive neutrophil mobilization after intraperitoneal E. coli infection,
echoing the Nocardia study (Shibata et al., 2007; King et al.,
1999).
Human gd cells are also implicated in responses to virus-
infected cells that accumulate IPP (Gober et al., 2003) (Figure 2).
Among other virus infections, gd-deficiency impairs both primary
and memory CD8+ T cell responses to infection by West Nile
Virus (an emerging mosquito-borne disease), even though gd
cells do not directly contribute to the recall response (Wang
et al., 2006). This emphasizes the potential for gd cells to provide
protection both directly and indirectly, with the immediate
production of cytokines, chemokines, and other regulators
during stress surveillance having potentially profound effects
on downstream adaptive immunity.
Tumor Surveillance and More
Tumor surveillance is a key component of lymphoid stress
surveillance, in which recognition of transformation-induced
changes provides local protection (for example, cytolysis) and
may enhance tumor immunogenicity. Consistent with this,
Tcrd/ mice and DETC-deficient mice both show increased
vulnerability to cutaneous chemical carcinogenesis (Girardi
et al., 2001; Strid et al., 2008). In line with the stress-surveillance
model, the gd cells act early, suppressing papilloma incidence,
but cannot suppress progression of papillomas into carcinomas
(Strid et al., 2008). This emphasizes the challenge posed by
advanced tumors, and gd cells infiltrating human breast and
prostate carcinomas were on aggregate immunosuppressive
(Peng et al., 2007). Nkg2d/ mice are also more vulnerable to
carcinomas, although this cannot simply be attributed to
stress-surveillance by unconventional T cells (Guerra, et al.,
2008).
Because tumor-associated antigens are often expressed by
normal cells, conventional antitumor responses predictably
dispose to autoimmunity. For lymphoid stress surveillance, it
may be even more challenging to distinguish bona fide dysregu-
lation from benign upregulation of ligands for TCRgd, NKG2D, or
other receptors. Thus, unconventional T cells might respond
inappropriately in the context of genetic abnormalities, such as
loss-of-function alleles of filaggrin that affect epidermal barrier
function and predispose to eczema (Regan et al., 2008). Likewise,
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by allergens, as in the perturbation of enterocytes by gliadin
peptides. Indeed, both MICA and gd cells are consistently impli-
cated in celiac disease (Hu¨e et al., 2004; Meresse et al., 2004).
Chronic stress-antigen expression might specifically provoke
gd-17 cells, perhaps explaining how gd cells exacerbate EAE
(Jensen et al., 2008; Sutton et al., 2009), and how Vg4+gd-17 cells
exacerbate CIA disease (Roark et al., 2007). Cautioning once
more against generalizations, gd cells also ameliorate several
autoimmune pathologies, reminding us of their anti-inflammatory
potentials (Hayday and Geng, 1997; Hayday, 2000).
Lymphoid Stress Surveillance in the Clinic
By contributing to immunoprotection, immunoregulation, and
immunopathologies, gd cells emerge as targets for clinical inter-
vention. This prospect is all the more attractive given the relative
ease of activating gd cells with P-antigens and aminobisphosph-
onates, with or without cytokines and TLR-agonists (Kunzmann
et al., 1999; Gougeon, et al., 2002; Sicard et al., 2005; Beetz
et al., 2007). In recent years, such approaches have been applied
to carcinoma, lymphoma, and myeloma (Wilhelm et al., 2003;
Dieli et al., 2007), based on the hypothesis that activated gd
cells can home to a tumor, recognize it via NKG2D or the TCR,
rapidly deploy key effectors, and enhance systemic adaptive
responses. Results to date suggest that this is a safe and moder-
ately efficacious approach that merits optimization (Beetz et al.,
2007). Perhaps most importantly, effector functions such as
IFNg and TRAIL production could be upregulated in bulk gd
cell populations, even in individuals in very poor health (Dieli
et al., 2007). Chronic gd cell activation in vivo may induce
exhaustion or anergy (see above), to offset which one may adop-
tively transfer autologous gd cells activated ex vivo. For different
applications, such cells that might even be transduced with
virus-specific or tumor-specific ab TCRs. Strongly encouraging
such approaches, gd cell reconstitution was recently disclosed
as the clearest long-term correlate of graft-versus-leukemia
activity in patients transfused with T-depleted bone marrow
(Godder et al., 2007). Conversely, increasing attention will likely
be paid to the deleterious contribution of the lymphoid stress-
surveillance response to some autoimmune and inflammatory
scenarios. Again, the biological properties of the response,
such as its oligoclonality, may render it a practical target. In
short, the intensified study of gd cells promises to fill gaps in
our clinical armamentarium, as well as some major gaps in our
understanding of the immunobiology of microbial and nonmicro-
bial perturbation.
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